Brian I. Rini, MD

Vanderbilt

Brian I. Rini, MD, FASCO, is the Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Professor of Medicine at Vanderbilt University, where he leads kidney cancer clinical research efforts and the expansion of cancer clinical research operations. His research activities include over 300 publications extensively covering genitourinary cancer, most notably renal cell carcinoma. Dr. Rini has been lead investigator of several phase 3 clinical trials which have led to FDA approval. He has spoken at numerous seminars and invited lectureships, locally, nationally, and internationally, on genitourinary cancers and their treatments. He is a member of ASCO, KCA (Kidney Cancer Association) and SITC (Society for Immunotherapy of Cancer) with leadership positions in these organizations. He recently completed a term as a member and immediate past Chair of the Oncologic Drugs Advisory Committee (ODAC).

Disclosure information not submitted.

Presentation(s):

• Management of Metastatic Non-Clear Cell RCC

  Saturday, April 29, 2023
  1:11 PM – 1:20 PM CST

• 060IC - Managing Toxicities of Checkpoint Inhibitors: A Urologist's Guide

  Sunday, April 30, 2023
  1:30 PM – 3:30 PM CST